PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients

OBJECTIVE: Thrombolysis by recombinant tissue plasminogen activator (rt‐PA) is the main pharmacological therapy in acute ischemic stroke (IS); however, it is only effective in a subset of patients. Here we aimed to investigate the role of plasminogen activator inhibitor‐1 (PAI‐1), an effective inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Szegedi, István, Nagy, Attila, Székely, Edina G., Czuriga‐Kovács, Katalin R., Sarkady, Ferenc, Lánczi, Levente I., Berényi, Ervin, Csiba, László, Bagoly, Zsuzsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856768/
https://www.ncbi.nlm.nih.gov/pubmed/31637872
http://dx.doi.org/10.1002/acn3.50923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856768/
https://www.ncbi.nlm.nih.gov/pubmed/31637872
http://dx.doi.org/10.1002/acn3.50923

Ejemplares similares